Please Wait
Applying Filters...
menu
    • menu
    Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Zocor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 218Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    01/01/2026 Artemis Biotech
    India
    		 M/s. Artemis Biotech WC-0175 Simvastatin EP 2025-11-25 2028-07-21 (A Division of Themis Medicare Ltd.) Plot No. 1 and 5 IDA Phase-l,Jeedimetla Quthbullapur (Mandal),Medchal -Malkajgiri District, Telangana, India
    25/09/2025 Aurobindo Pharma Limited
    India
    		 M/s. Apitoria Pharma Private Limited WC-0120 Simvastatin Ph. Eur 2025-07-11 2028-07-02 UNIT -I, Sy.Nos. 379, 385, 386, 388 to 396, Borpatla Village, Hathnoora Mandal, Sangareddy District -502296, Telangana State, India.
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.